Hypercalcaemia with topical calcipotriol.
Bourke
J F
JF
Berth-Jones
J
J
Hutchinson
P E
PE
D000287:Administration, Topical; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy
D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol